Topical Sirolimus for Refractory Cutis Marmorata Telangiectatica Congenita in Adulthood: A Case Report.

J Drugs DermatolSep 1, 2026
Case ReportDermatology

Ram D Bhatt, Kateryna Karpoff, Nicholas Heitman et al.

✦ AI-curated · Sources linked

Case in brief

A 50-year-old woman with a history of congenital livedo reticularis and Raynaud syndrome presented with unilateral left lower-extremity hypoplasia and painful ulcerations due to cutis marmorata telangiectatica congenita (CMTC). Despite multiple therapies failing to alleviate her symptoms, treatment with once-daily topical sirolimus led to significant pain reduction and healing of ulcers within two months.

Diagnostic / clinical pearl

Clinicians should consider cutis marmorata telangiectatica congenita in adults presenting with atypical skin changes and painful ulcerations, especially when other treatments have failed.

Why it matters

This case highlights the potential of topical sirolimus as an effective off-label treatment for chronic ulcerative disease associated with adult CMTC.

Source

Published in J Drugs Dermatol. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Dermatology

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.